Kidney transplant patients get extra COVID shot in new trial
Disease control
Terminated
This phase 3 trial tested whether a dose of the Janssen COVID-19 vaccine could boost immunity in kidney transplant recipients who had already received two or three mRNA vaccine doses. The study enrolled 468 participants and also looked at reducing immunosuppression medication. Ho…
Phase: PHASE3 • Sponsor: Mark Stegall • Aim: Disease control
Last updated Jun 26, 2026 17:26 UTC